Donors should continue to provide AIDS funding to China, UNAIDS head says

Cutting AIDS funding to China will "be a big mistake for a donor and particularly, for anyone who's invested in China today, ... for the simple reason that this funding is a catalytic fund," UNAIDS Executive Director Michel Sidibe told Reuters in an interview on Monday.

Speaking in Beijing on the sidelines of "the first meeting of BRICS health ministers, made up of emerging markets of Brazil, Russia, India, China and South Africa," Sidibe "rebuff[ed] critics who say the world's second-largest economy should no longer be a recipient of such aid," Reuters reports. "Sidibe said the Global Fund to Fight Aids, Tuberculosis and Malaria was helping to bring innovation and make a difference in most-affected countries by establishing a new link among the government and civil society and NGOs to work together," the news service writes, noting that the "Global Fund has approved funding of $947 million to China, of which $369 million goes to fighting AIDS" (Wee, 7/11).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic